跳至主要内容
临床试验/IRCT201010194970N1
IRCT201010194970N1已完成未知

Ginger efficacy in patients uncontrolled on standard moderate asthma treatment: a randomized, double-blind, placebo-controlled, cross-over study

Mazandaran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 70 years(—)
性别
All

入选标准

  • 40 consenting non-smoking patients aged between 16 and 70 years with a documented positive bronchodilator reversibility test with = 15% improvement in FEV1 from 15 to 30 minutes after inhalation of at least 200 µg of salbutamol are enrolled in the 10-week, randomized controlled cross over study.
  • Exclusion criteria for the study are: emergency treatment for an asthma exacerbation within one month, COPD, upper airway infections in the last three weeks, hospitalization for asthma in the three months previous to enrolment, treatment with antihistamines, anticholinergics, theophyline and chromones, oral corticosteroids and ß2 agonists, presence of autoimmune, cardiac, hepatic or renal disorders, malabsorption, drug-addiction, pregnancy and lactation.

排除标准

  • 未提供

研究者

相似试验

Ginger efficacy in patients uncontrolled on standard... | 临床试验